?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
The Issue
Our Solutions
Biosimilars 101
Foundations
Core Principles
FDA Regulatory Tenets
Biosimilars FAQs
Future Evolution of Biosimilar Development
Approved Biosimilars
Advocacy
Our Action
Tools
News
Resources
Get Involved
Partners
Katie Quinn
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
July 11, 2019
Katie Quinn
New Analysis Confirms Increased Use of Biosimilars Can Save U.S. Up to $71 Billion Over a Decade
News
June 20, 2019
Katie Quinn
Health Experts Agree Increasing Biosimilar Use Can Help Reduce Rising Drug Costs for Patients
News
May 29, 2019
Katie Quinn
Biosimilars Forum Announces Support for Policies that Would Save Taxpayers and Seniors Billions
News
May 23, 2019
Katie Quinn
The Biosimilars Forum Commends Senate HELP Committee’s Effort to Educate Patients and Providers on Biosimilars
News
March 19, 2019
Katie Quinn
Significant Healthcare Savings Possible if U.S. Cultivates a Robust Biosimilars Market
News
March 7, 2019
Katie Quinn
The Biosimilars Forum Disagrees with the Food and Drug Administration’s Decision on Naming of Biologic Medicines
News
March 6, 2019
Katie Quinn
The Biosimilars Forum Recognizes Commissioner Gottlieb’s Leadership Supporting a Strong Biosimilars Market in the U.S.
News
February 26, 2019
Katie Quinn
Removing 340B Pass-Through Would be Detrimental to US Healthcare Savings
News
February 26, 2019
Katie Quinn
The Biosimilars Forum Urges Senate Finance Committee to Seek Meaningful Biosimilars Reform
News
February 12, 2019
Katie Quinn
The Biosimilars Forum Objects to Consolidate Billing of Biosimilars
Prev page
01
02
03
04
Next page